Vulnerability Details : CVE-2022-0653
The Profile Builder – User Profile & User Registration Forms WordPress plugin is vulnerable to Cross-Site Scripting due to insufficient escaping and sanitization of the site_url parameter found in the ~/assets/misc/fallback-page.php file which allows attackers to inject arbitrary web scripts onto a pages that executes whenever a user clicks on a specially crafted link by an attacker. This affects versions up to and including 3.6.1.
Vulnerability category: Cross site scripting (XSS)
Products affected by CVE-2022-0653
- cpe:2.3:a:cozmoslabs:profile_builder:*:*:*:*:*:wordpress:*:*
Exploit prediction scoring system (EPSS) score for CVE-2022-0653
0.22%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 60 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2022-0653
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
4.3
|
MEDIUM | AV:N/AC:M/Au:N/C:N/I:P/A:N |
8.6
|
2.9
|
NIST | |
6.1
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N |
2.8
|
2.7
|
NIST | |
6.1
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N |
2.8
|
2.7
|
Wordfence |
CWE ids for CVE-2022-0653
-
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.Assigned by:
- nvd@nist.gov (Primary)
- security@wordfence.com (Secondary)
References for CVE-2022-0653
-
https://www.wordfence.com/blog/2022/02/reflected-cross-site-scripting-vulnerability-patched-in-wordpress-profile-builder-plugin/
Reflected Cross-Site Scripting Vulnerability Patched in WordPress Profile Builder PluginExploit;Third Party Advisory
-
https://plugins.trac.wordpress.org/changeset?sfp_email=&sfph_mail=&reponame=&old=2655168%40profile-builder&new=2655168%40profile-builder&sfp_email=&sfph_mail=
Changeset 2655168 for profile-builder – WordPress Plugin RepositoryPatch;Third Party Advisory
Jump to